Both in Pharmaceuticals
GT Biopharma vs MetaVia
Over the past year GTBP returned −68.1% and MTVA returned −87.2%; their daily moves had a correlation of 0.01.
GTBP −68.1% MTVA −87.2%Growth of $1, one year, split-adjusted
| Metric | GTBP | MTVA |
|---|---|---|
| Price | $5.46 | $1.38 |
| Market cap | $9.9M | $9.1M |
| Today | −1.09% | −0.72% |
| 1 month | −20.1% | −15.3% |
| 6 months | −30.1% | −11.5% |
| Year to date | −72.2% | −83.6% |
| 1 year | −67.4% | −86.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 958.1% | 54.5% |
| Short % of float | 22.4% | 3.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).